Correlation between IDH mutation status, genome-wide copy number abundance and tumor blood volume in diffuse gliomas: a TCGA/TCIA project and multi-institute study
Recommended Citation
Wu CC, Poisson LM, Neto L, Ng V, Patel S, Snuderl M, Zagzag D, Placantonakis D, Golfinos J, Chi AS, and Jain R. Correlation between IDH mutation status, genome-wide copy number abundance and tumor blood volume in diffuse gliomas: a TCGA/TCIA project and multi-institute study. Neuroradiology 2018; 60(1):324-325.
Document Type
Conference Proceeding
Publication Date
2018
Publication Title
Neuroradiol
Abstract
Purpose: Prior studies have shown correlation between relative cerebral blood volume (rCBV) and patient survival and tumor genomics. The purpose of this study was to determine whether rCBV values correlate with isocitrate dehydrogenase (IDH) mutation status, genome-wide CNV (copy number variation) and patient overall survival in diffuse gliomas. Materials & Methods: 107 treatment naive gliomas (62 patients from TCGA/TCIA dataset and 45 patients from our institute) (44 glioblastoma and 63 lower grade gliomas) with DSC T2∗ perfusion data were included. IDH mutation and survival data were assayed by the TCGA, and pre-surgical imaging collected by The Cancer Imaging Archive. CNVabundance plots obtained with Illumina 850k EPIC DNA methylation arrays were reviewed in 19 patients. The association of rCBV with tumor genomics, CNV and overall survival were analyzed. Results: IDH-wildtype gliomas (44.8%) demonstrated higher rCBV values (rCBV = 6.87 ± 3.09) than IDH-mutated gliomas (55.2%, rCBV =2.21 ± 1.71 for 1p/19q codeleted gliomas and 2.09 ± 2.00 for non-codeleted gliomas, ANOVA, p<0.0001). rCBV is a significant predictor of overall survival (HR 1.23, p<0.0001). Gliomas with rCBV < 3.80 showed better survival (n = 54, median survival time unobserved) than gliomas with rCBV > 3.8 (n = 53, median 18 months; log-rank p<0.0001). IDHwt gliomas with high rCBV had the worst survival (10.6% surviving at 3 years, 95% CI (4%, 30%)). CNV-S IDHmut 1p19q noncodeleted gliomas demonstrated significantly lower mean rCBV (1.4 ± 0.4) than CNV-U gliomas (4.0 ± 1.1, p = 0.009). Conclusion: IDHwt gliomas show higher rCBV than IDHmut gliomas irrespective of the glioma grade. Higher rCBV measurements are associated with poorer survival in the entire cohort and also within IDHmut and IDHwt gliomas. IDHmut 1p19q noncodeleted gliomas with higher CNV abundance (CNV-U) also show higher CBV when compared with those with lesser degree of CNVabundance (CNV-S).
Volume
60
Issue
15
First Page
324
Last Page
325
